Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Mild and Moderate Renal Impairment”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT03259087
What this trial is testing

Pharmacokinetics (PK) and Safety of a Single Intravenous (IV) Dose of MK-3866 in Participants With Impaired Renal Function and in Healthy Controls (MK-3866-005)

Who this might be right for
Renal Impairment
Merck Sharp & Dohme LLC 42
Early research (Phase 1)Study completedNCT01444872
What this trial is testing

Study to Evaluate TRV120027 on Renal Pharmacodynamics in Patients With Heart Failure and Renal Dysfunction

Who this might be right for
Heart FailureKidney Disease
Trevena Inc. 17
Early research (Phase 1)Study completedNCT03814005
What this trial is testing

Pevonedistat in People With Blood Cancers or Solid Tumors With Kidney or Liver Problems

Who this might be right for
Myelodysplastic SyndromesLeukemia, Myelomonocytic, ChronicLeukemia, Myeloid, Acute+3 more
Takeda 17
Early research (Phase 1)Not Yet RecruitingNCT07445906
What this trial is testing

RG002C0106 Injection in Adult Participants With Normal Renal Function and Mild-to-Moderate Renal Impairment

Who this might be right for
Renal ImpairmentsIgA Nephropathy (IgAN)
Rigerna Therapeutics Co., Ltd.; Rigerna Therapeutics (Beijing) Co., Ltd. 24
Post-approval studies (Phase 4)Study completedNCT01172431
What this trial is testing

Indapamide Versus Hydrochlorothiazide in Elderly Hypertensive Patients With Renal Insufficiency

Who this might be right for
HypertensionRenal Insufficiency
West China Hospital 240
Early research (Phase 1)Study completedNCT00999336
What this trial is testing

Determine the Pharmacokinetics, Pharmacodynamics, and Tolerabiltiy of Betrixaban in Patients With Mild, Moderate, and Severe Renal Impairment

Who this might be right for
Renal Impairment
Portola Pharmaceuticals 32
Early research (Phase 1)Study completedNCT05431426
What this trial is testing

PK of CHF6001 in Subjects With Mild, Moderate and Severe Renal Impairment vs. Healthy Volunteers

Who this might be right for
Chronic Obstructive Pulmonary Disease
Chiesi Farmaceutici S.p.A. 44
Early research (Phase 1)Study completedNCT01569815
What this trial is testing

Pharmacokinetics of LCZ696 in Subjects With Mild and Moderate Renal Impairment Compared to Healthy Subjects With Normal Renal Function

Who this might be right for
Mild and Moderate Renal Impairment
Novartis Pharmaceuticals 32
Early research (Phase 1)Study completedNCT05117294
What this trial is testing

ASP0367 in People With Kidneys That do Not Work Well and in Healthy People

Who this might be right for
Renal ImpairmentHealthy Volunteers
Astellas Pharma Global Development, Inc. 13
Testing effectiveness (Phase 2)Study completedNCT03115736
What this trial is testing

TAF for HIV-HBV With Renal Dysfunction

Who this might be right for
HIV and Hepatitis B Coinfection
Insel Gruppe AG, University Hospital Bern 24
Large-scale testing (Phase 3)Study completedNCT00273871
What this trial is testing

Study Comparing Conversion From Calcineurin Inhibitors to Rapamune Versus Standard Therapy in Established Renal Allograft Recipients

Who this might be right for
Graft RejectionKidney FailureKidney Transplantation
Wyeth is now a wholly owned subsidiary of Pfizer 190
Early research (Phase 1)Study completedNCT03097016
What this trial is testing

Assess the Pharmacokinetics of CC-122 in Subjects With Mild, Moderate, and Severe Renal Impairment

Who this might be right for
Renal Insufficiency
Celgene 48
Not applicableStudy completedNCT01721837
What this trial is testing

Dabigatran Etexilate for Stroke Prevention in Patients With Atrial Fibrillation and Mild to Moderate Renal Impairment

Who this might be right for
Atrial Fibrillation
Boehringer Ingelheim 4,340
Early research (Phase 1)Study completedNCT01442259
What this trial is testing

An Open-label, Parallel-group Study to Determine the Pharmacokinetics of a Single Dose of AFQ056 in Subjects With Renal Impairment Compared to Healthy Subjects

Who this might be right for
Mild Moderateor Severe Renal Impairment
Novartis Pharmaceuticals 48
Early research (Phase 1)Ended earlyNCT00984113
What this trial is testing

Pharmacokinetics of Elinogrel in Healthy Volunteers and Patients With Mild, Moderate, and Severe Renal Impairment

Who this might be right for
Renal Impairment
Portola Pharmaceuticals 44
Early research (Phase 1)Study completedNCT05895812
What this trial is testing

A Study in Subjects With Renal Impairment Compared to Subjects With Normal Renal Function

Who this might be right for
Subjects With Renal ImpairmentHealthy Subjects
Shanghai Vinnerna Biosciences Co., Ltd. 24
Early research (Phase 1)Study completedNCT02674581
What this trial is testing

The Pharmacokinetics and Safety of BMS-663068 Administered in Subjects With Normal Renal Function and With Mild, Moderate, Severe and End Stage Renal Dysfunction (ESRD)

Who this might be right for
HIV Infections
ViiV Healthcare 30
Early research (Phase 1)Study completedNCT01674192
What this trial is testing

Prucalopride Subjects With Renal Impairment

Who this might be right for
Constipation
Movetis 34
Early research (Phase 1)Study completedNCT05368935
What this trial is testing

Nitazoxanide Pharmacokinetic Parameters in Renal Impaired Subjects

Who this might be right for
Renal ImpairmentRenal DiseaseKidney Disease
Genfit 77
Early research (Phase 1)Study completedNCT01894256
What this trial is testing

Study to Assess the Blood Levels and Safety of Olaparib in Patients With Advanced Solid Tumours and Normal or Impaired Kidney Function

Who this might be right for
Solid Tumours
AstraZeneca 56
Next Page